Go Pro
NASDAQ:AVAH

Aveanna Healthcare (AVAH) Stock Price, News & Analysis

Aveanna Healthcare logo
$13.12 -0.09 (-0.64%)
As of 10:04 AM Eastern
This is a fair market value price provided by Massive. Learn more.

About Aveanna Healthcare Stock (NASDAQ:AVAH)

Advanced

Key Stats

Today's Range
$13.12
$13.39
50-Day Range
$8.48
$13.82
52-Week Range
$5.93
$14.00
Volume
102,243 shs
Average Volume
1.83 million shs
Market Capitalization
$2.86 billion
P/E Ratio
10.65
Dividend Yield
N/A
Price Target
$13.50
Consensus Rating
Moderate Buy

Company Overview

Aveanna Healthcare, Inc. (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies. The company’s interdisciplinary care teams collaborate with families, physicians and payors to develop individualized care plans that address evolving patient needs. By combining clinical expertise with care coordination, Aveanna strives to improve patient outcomes and enhance quality of life for both children and adults requiring long-term or specialized in-home care.

Aveanna Healthcare maintains a network of more than 100 service locations across over 25 states, with a presence in major metropolitan and suburban markets throughout the Southeast, Northeast, Midwest and West. Its operational footprint includes established service lines in Texas, Florida, Pennsylvania, North Carolina, Massachusetts, Illinois and Georgia, among others. The company’s head office is based in Houston, Texas, serving as the hub for corporate leadership, strategic development and clinical quality oversight.

Founded in 2017 through the consolidation of regional home health and pediatric care providers, Aveanna has grown both organically and through targeted acquisitions aimed at expanding its geographic reach and service capabilities. The company is led by President and Chief Executive Officer William F. Allen, whose background in health care operations and private-equity-backed services has guided Aveanna’s focus on scaling integrated care solutions and fostering partnerships with hospitals, health systems and payors.

AI Generated. May Contain Errors.

Aveanna Healthcare Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
77th Percentile Overall Score

AVAH MarketRank™: 

Aveanna Healthcare scored higher than 77% of companies evaluated by MarketBeat, and ranked 208th out of 914 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Aveanna Healthcare has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on 1 strong buy rating, 6 buy ratings, 5 hold ratings, and no sell ratings.

  • Upside/Downside

    The consensus price target for Aveanna Healthcare is close to its current price, suggesting limited near-term upside or downside.

  • Amount of Analyst Coverage

    Aveanna Healthcare has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Aveanna Healthcare's stock forecast and price target.
  • Earnings Growth

    Earnings for Aveanna Healthcare are expected to grow by 12.00% in the coming year, from $0.75 to $0.84 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Aveanna Healthcare is 10.73, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 39.09.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Aveanna Healthcare is 10.73, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 272.68.

  • Price to Earnings Growth Ratio

    Aveanna Healthcare has a PEG Ratio of 0.85. PEG Ratios below 1 indicate that a company could be undervalued.

  • Price to Book Value per Share Ratio

    Aveanna Healthcare has a P/B Ratio of 10.00. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Aveanna Healthcare's valuation and earnings.
  • Percentage of Shares Shorted

    2.59% of the float of Aveanna Healthcare has been sold short.
  • Short Interest Ratio / Days to Cover

    Aveanna Healthcare has a short interest ratio ("days to cover") of 1.64, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Aveanna Healthcare has recently increased by 20.95%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Aveanna Healthcare does not currently pay a dividend.

  • Dividend Growth

    Aveanna Healthcare does not have a long track record of dividend growth.

  • News Sentiment

    Aveanna Healthcare has a news sentiment score of 1.07. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.79 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 13 news articles for Aveanna Healthcare this week, compared to 6 articles on an average week.
  • Search Interest

    Only 15 people have searched for AVAH on MarketBeat in the last 30 days. This is a decrease of -38% compared to the previous 30 days.
  • MarketBeat Follows

    Only 4 people have added Aveanna Healthcare to their MarketBeat watchlist in the last 30 days. This is a decrease of -69% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Aveanna Healthcare insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $773,117,091.00 in company stock.

  • Percentage Held by Insiders

    5.30% of the stock of Aveanna Healthcare is held by insiders.

  • Percentage Held by Institutions

    87.96% of the stock of Aveanna Healthcare is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Aveanna Healthcare's insider trading history.
Receive AVAH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aveanna Healthcare and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

AVAH Stock News Headlines

A letter from Shannon Stansberry
Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down year in nearly two decades and total gains of almost 2,000% - his immediate reaction was disbelief. It took a trusted friend's personal vouching for Emmet Savage and a face-to-face trip to Ireland to change his mind. The full documentary, Investigating Project Prophet, is now live.tc pixel
See More Headlines

AVAH Stock Analysis - Frequently Asked Questions

Aveanna Healthcare's stock was trading at $8.17 on January 1st, 2026. Since then, AVAH shares have increased by 61.6% and is now trading at $13.20.

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) released its earnings results on Thursday, August, 13th. The company reported $0.22 earnings per share for the quarter, topping analysts' consensus estimates of $0.17 by $0.05. The business earned $670.48 million during the quarter, compared to analysts' expectations of $638.61 million. Aveanna Healthcare had a trailing twelve-month return on equity of 80.70% and a net margin of 10.56%.
Read the conference call transcript
.

Aveanna Healthcare (AVAH) raised $478 million in an initial public offering on Thursday, April 29th 2021. The company issued 38,200,000 shares at a price of $12.00-$13.00 per share. Barclays, J.P. Morgan, BMO Capital Markets and Credit Suisse served as the underwriters for the IPO and BofA Securities, Deutsche Bank Securities, Jefferies, RBC Capital Markets, Truist Securities, Raymond James, Stephens Inc., Drexel Hamilton and Siebert Williams Shank were co-managers.

Aveanna Healthcare's top institutional investors include BlackRock Inc. (3.40%), Braidwell LP (1.40%), Algert Global LLC (0.74%) and Connor Clark & Lunn Investment Management Ltd. (0.42%). Insiders that own company stock include Robert M Williams Jr, Paul R Vigano, JH Whitney Equity Partners V, Jeff Shaner, Rodney D Windley, Edwin C Reisz, Matthew Buckhalter, Deborah Stewart and Patrick A Cunningham.
View institutional ownership trends
.

Shares of AVAH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Aveanna Healthcare investors own include American Water Works (AWK), Waste Connections (WCN), The RMR Group (RMR), AUO (AUOTY), DiamondRock Hospitality (DRH), iShares Micro-Cap ETF (IWC) and Voyager Therapeutics (VYGR).

Company Calendar

Last Earnings
8/13/2026
Today
9/03/2026
Healthcare Services and Technology Conference
9/15/2026
2026 Healthcare Summit
9/16/2026
Next Earnings (Estimated)
11/05/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Providers & Services
Sub-Industry
Healthcare Services
Current Symbol
NASDAQ:AVAH
CIK
1832332
Fax
N/A
Employees
35,500
Year Founded
2017

Price Target and Rating

High Price Target
$16.00
Low Price Target
$10.00
Potential Upside/Downside
+2.3%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.67
Research Coverage
12 Analysts

Profitability

EPS (Trailing Twelve Months)
$1.23
Trailing P/E Ratio
10.73
Forward P/E Ratio
17.60
P/E Growth
0.85
Net Income
$225.03 million
Net Margins
10.56%
Pretax Margin
5.92%
Return on Equity
80.70%
Return on Assets
7.42%

Debt

Debt-to-Equity Ratio
4.47
Current Ratio
1.16
Quick Ratio
1.16

Sales & Book Value

Annual Sales
$2.43 billion
Price / Sales
1.18
Cash Flow
$0.68 per share
Price / Cash Flow
19.52
Book Value
$1.32 per share
Price / Book
10.00

Miscellaneous

Outstanding Shares
218,220,000
Free Float
206,654,000
Market Cap
$2.88 billion
Optionable
Optionable
Beta
1.97

Social Links

7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

This page (NASDAQ:AVAH) was last updated on 9/3/2026 by MarketBeat.com Staff.
From Our Partners